-An inorganic phosphate (P i)-restricted diet is important for patients with chronic kidney disease and patients on hemodialysis. Phosphate binders are essential for preventing hyperphosphatemia and ectopic calcification. The sodium-dependent P i (Na/Pi) transport system is involved in intestinal P i absorption and is regulated by several factors. The type II sodium-dependent P i transporter Npt2b is expressed in the brush-border membrane in intestinal epithelial cells and transports P i. In the present study, we analyzed the phenotype of Npt2b Ϫ/Ϫ and hetero ϩ/Ϫ mice. Npt2b Ϫ/Ϫ mice died in utero soon after implantation, indicating that Npt2b is essential for early embryonic development. At 4 wk of age, Npt2b ϩ/Ϫ mice showed hypophosphatemia and low urinary P i excretion. Plasma fibroblast growth factor 23 levels were significantly decreased and 1,25(OH) 2D3 levels were significantly increased in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice. Npt2b mRNA levels were reduced to 50% that in Npt2b ϩ/ϩ mice. In contrast, renal Npt2a and Npt2c transporter protein levels were significantly increased in Npt2b ϩ/Ϫ mice. At 20 wk of age, Npt2b ϩ/Ϫ mice showed hypophosphaturia and reduced Na/P i cotransport activity in the distal intestine. Npt2b ϩ/ϩ mice with adenine-induced renal failure had hyperphosphatemia and high plasma creatinine levels. Npt2b ϩ/Ϫ mice treated with adenine had significantly reduced plasma Pi levels compared with Npt2b ϩ/ϩ mice. Intestinal Npt2b protein and Na ϩ /Pi transport activity levels were significantly lower in Npt2b ϩ/Ϫ mice than in the Npt2b ϩ/ϩ mice. The findings of the present studies suggest that Npt2b is an important target for the prevention of hyperphosphatemia.
mouse; phosphate; slc34a2; intestine; transporter INTESTINAL ABSORPTION OF INORGANIC phosphate (P i ) has been characterized in several mammalian and avian species (5, 28, 31, 32) . Studies conducted with isolated intestinal brush-border membrane vesicles (BBMVs) have demonstrated that the transepithelial uptake of P i occurs primarily in the proximal and distal small intestine secondary to passive diffusion across the intestinal brush border and Na ϩ -dependent, carrier-mediated uptake (5, 29, 30) . Three types of sodium-dependent P i cotransporters have been identified (5) . The type II sodium phosphate transporter family is important for epithelial P i transport (5, 6, 10, 29) . Type IIa (Npt2a), type IIc (Npt2c), and type III (PiT-2) sodium-phosphate transporters are expressed in the apical membrane of renal proximal tubular cells and contribute to renal P i reabsorption (5, 6, 10, 29) . Intestinal absorption of P i is mediated primarily via the type IIb sodiumphosphate transporter Npt2b (29, 40, 43, 44) . 1,25-Dihydroxyvitamin D 3 and dietary P i depletion are thought to be the most important physiological stimuli of intestinal P i absorption and act by increasing the abundance of Npt2b protein (11, 16, 27, 42) .
In chronic renal failure, P i retention leads to secondary hyperparathyroidism and uremic bone disease and progression to end-stage renal disease (13, 14, 25) . The current therapy for hyperphosphatemia in patients with chronic renal failure consists of dietary P i restriction in combination with administration of P i binders, but each therapy has practical problems (8, 24) . Dietary restriction of P i is limited by poor patient compliance (20, 21) . Therefore, other therapeutic approaches to reduce serum P i are needed. In addition, in animals with chronic renal failure (CRF), phosphate transport (via the Npt2b protein) across the small intestine is not reduced (23) . Therefore, Npt2b is a primary target for the developmental of inhibitors of hyperphosphatemia (23) . We previously reported that Npt2b inhibitor significantly decreases intestinal P i absorption in normal animals (26) .
Recently, Sabbagh et al. (35) demonstrated that in Npt2b conditional knockout (KO) mice, intestinal Npt2b plays a major role in P i absorption and homeostasis. They also reported that Npt2b is largely responsible for intestinal P i absorption and contributes to the maintenance of systemic P i homeostasis (35) . The roles of Npt2b in CRF mice, however, remain unknown. In the present study, we characterized P i homeostasis in Npt2b ϩ/Ϫ mice. The present study demonstrated that Npt2b ϩ/Ϫ mice have significantly reduced intestinal Na ϩ -dependent P i co-transport activity in the BBMVs. In addition, plasma P i concentrations in the Npt2b ϩ/Ϫ mice with adenine-induced renal failure were significantly decreased compared with Npt2b ϩ/ϩ mice.
MATERIALS AND METHODS

Construction of the Npt2b gene-targeting vector.
The bacterial artificial chromosome (BAC) clone carrying a genomic DNA containing the full-length mouse Npt2b gene was purchased from Invitrogen (Carlsbad, CA). To construct a targeting vector for Npt2b gene disruption, the BAC clone was modified using the Red/ET system (Quick and Easy BAC Modification kit, GeneBridges) (3, 33) . First, a PCR product containing the neomycin-resistant gene cassette (pgkgb2-NeoR, GeneBridges) was used to replace exons 2-4 of Npt2b on the BAC clone. A NotI site was then created at ϳ1.5 kb upstream from the pgk-gb2-NeoR insertion site for linearization of the targeting construct before electroporation into embryonic stem (ES) cells (35) .
Generation of Npt2b gene KO mice. The targeting vector was introduced by electroporation (200 V, 500 F) into mouse ES cells (TX-MES-01, Thromb-X N.V.), which were established from 129SvEvTacfBr. The ES cells were selected in a medium containing G418. G418-resistant ES cell clones were screened by PCR using the primers Npt2b 74991 (5=-TGGACCACATCTCAGCCATAC-3=) and pgk-antisense (5=-GCTGTCCATCT GCACGAGAC-3=) to select homologous recombinants. Homologous recombinant ES cell clones were injected into C57BL/6J (B6) mouse (CLEA Japan) blastocysts to produce chimera mice. Chimera mice were bred with B6 females to generate offspring. Germline transmission of the mutation was determined by PCR analysis using tail genomic DNA of the offspring. The positions of the PCR primers are shown in Fig. 1A . To detect the null allele, the PCR product was amplified by the Npt2b 74991 and pgk-antisense primer set. After an initial denaturation at 95°C for 1 min, 35 cycles (95°C for 30 s, 66°C for 30 s, and 72°C for 90 s) were run using TaKaRa LA Taq (TaKaRa, Japan). To detect the wild-type allele, the PCR product was amplified by the Npt2b 74991 and Npt2b P4 (5=-GACCATTTGATCCCAGTGTCC-3=) primer set. After an initial denaturation at 94°C for 2 min, 30 cycles (94°C for 30 s, 68°C for 2 min) were run using TaKaRa LA Taq. PCR products of null and wild-type alleles were detected at 1.4 and 1.5 kb, respectively. Typical results of PCR analysis are shown in Fig. 1B .
Genotypes were determined by analyzing DNA obtained from each mouse at ϳ10 days after birth. Genomic DNA was extracted from tail clippings and amplified by PCR using primers specific for the Npt2b ϩ/ϩ exon 2-4 or for the neomycin-resistant gene. Novel primers with the sequences of 5=-GATGTGTGTATCTGAGCTTGTC-3= and 5=-CGAGGTCGACGGTATCGATA-3= were prepared for Npt2b and 5=-TTGCTCCTTCGCTTTCTGG-3= and 5=-CGATACCGTA-AAGCACGAGG-3= were prepared for detection of the neomycin resistance gene (Fig. 1A) .
Analysis of embryos. At 9.5-11.5 days postcoitum (dpc; plug date, 0.5 dpc), the embryos were dissected free of the decidua and yolk sac, the amnion was removed, and the embryos were then photographed under stereomicroscopic observation. Tissue from each embryo was used for genotyping. Genotyping was performed by PCR according to the above-described method for tail DNA.
Animals and diet. Mice (Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ ) were weaned at 3 wk of age and provided free access to water and standard mice chow (1.12% Ca and 0.9% P i; Oriental, Osaka, Japan). The Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mouse phenotypes were analyzed at 4, 9, and 20 wk of age. For the mouse CRF model, adenine-induced nephritis was produced in male mice at 9 wk of age by orally administering adenine dissolved in carboxymethyl cellulose (see Fig. 8 for the administration schedule). To induce adenine-induced nephritis, 7-wk-old male mice were administered adenine (50 -100 mg/kg body wt) dissolved in carboxymethyl cellulose three times orally (36) .
Mice were maintained under pathogen-free conditions and handled in accordance with the Guidelines for Animal Experimentation of Tokushima University School of Medicine or with the Guidelines for the Care and Use of Laboratory Animals at Chugai Pharmaceutical.
Preparation of BBMVs and transport assay. The mouse intestine was divided into two segments. The proximal intestine refers to the duodenum and the proximal part of the jejunum. The distal intestine refers to the late jejunum and ileum (16) . BBMVs were prepared from intestine using the Ca 2ϩ precipitation method and used for Western blotting analysis as described previously (37, 38) . Levels of leucine aminopeptidase, Na ϩ -K ϩ -ATPase, and cytochrome c oxidase were measured to assess membrane purity. There were no significant differences between the intestinal BBMVs of Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice regardless of whether they were or were not treated with adenine. Uptake of 32 P into BBMVs was measured by the rapid filtration technique as described previously (16, 37, 38) . The P i transport rate into the intestinal BBMV was determined at 60 s and at 60 min (equilibrium value) at 25°C with an inward gradient of 100 mM NaCl 2 or 100 mM KCl and 0.1 mM KH2PO4 (pH 7.5). The Na ϩ -dependent Pi transport activity (activity rate in the presence of Na ϩ or in the absence of Na ϩ ) is shown. All measurements were performed in triplicate.
Immunoblotting. Protein samples were heated at 95°C for 5 min in sample buffer in the presence of 2-mercaptoethanol and subjected to SDS-PAGE. The separated proteins were transferred by electrophoresis to Immobilon-P; polyvinylidene difluoride (Millipore, Billerica, MA) and then treated with diluted antibodies as follows: affinitypurified anti-Npt2a (1:8,000), anti-Npt2c (1:1,000), and anti-Npt2b antibody (1:2,000; Alpha Diagnostics, San Antonio, TX), and antiPiT-1 antibody (1:1,000; Santa Cruz Biotechnology) (37, 38) . Mouse anti-actin monoclonal antibody (Chemicon, Temecula, CA) was used as an internal control. Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG was utilized as the secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA), and signals were detected using Immobilon Western (Millipore).
Concentrations of P i, Ca, 1,25(OH)2D3, fibroblast growth factor 23, and creatinine. Concentrations of plasma and urinary inorganic P i and Ca were determined by the Phospha-C test and Calcium-E tests (Wako, Osaka, Japan), respectively. Concentrations of plasma 1,25(OH) 2D3 were determined using a 1,25-(OH)2-vitamin D ELISA Kit (Immundiagnostik, Bensheim, Germany). Concentrations of plasma fibroblast growth factor 23 (FGF23) proteins were determined using the FGF-23 ELISA kit (Kainos Laboratories, Tokyo, Japan). Concentrations of creatinine were determined using LabAssay Creatinine (Wako). Metabolic cages were used to collect the 24-h urine samples.
Statistical analysis. Data are expressed as means Ϯ SE. Differences among multiple groups were analyzed by ANOVA. The significance of differences between two experimental groups was established by ANOVA followed by Student's t-test. A P value of Ͻ0.05 was considered significant.
RESULTS
Generation of Npt2b gene KO mice. Heterozygous mice were obtained from three clones, 1C4, 1H1, and 4H5, which were indistinguishable from their wild-type littermates with respect to size, body weight, behavior, and reproductive ability. To obtain Npt2b Ϫ/Ϫ mice, heterozygous male and female mice were intercrossed. Of all the offspring delivered, no Npt2b Ϫ/Ϫ mice were produced; there were 222 heterozygous and 105 wild-type offspring (data not shown). This ratio of genotypes was compatible with the laws of Mendelian inheritance if the Npt2b Ϫ/Ϫ mice were embryonically lethal. At 9.5-11.5 dpc, 50 embryos were recovered from intercrosses of Npt2b ϩ/Ϫ mice. Approximately 20% of the recovered embryos had abnormal morphology or were resorbed. Most embryos with abnormal morphology were determined to be Npt2b Ϫ/Ϫ by PCR analysis (Fig. 1C) , whereas all embryos with normal morphology were determined to be wild-type or heterozygotes. These data indicate that the Npt2b Ϫ/Ϫ mice are embryonically lethal.
Body weight and growth and expression of Npt2b in Npt2b
ϩ/Ϫ mice. Npt2b ϩ/Ϫ mice were viable, had normal growth, and were without apparent abnormalities ( Fig. 2A) . Body weight development in heterozygous male and female mice fed the standard diet is illustrated in Fig. 2B . Until 20 wk of age, both genotypes showed a progressive body weight gain with no differences in body weight (Fig. 2B) .
Intestinal Npt2b levels were determined in Npt2b ϩ/Ϫ and Npt2b ϩ/ϩ mice fed the standard mice chow (Fig. 2, C and D) . In the proximal intestine and distal intestine, Npt2b mRNA levels were significantly decreased by ϳ50% in Npt2b ϩ/Ϫ mice at 4 wk of age (Fig. 2C) . In the proximal intestine of Npt2b ϩ/ϩ mice, Npt2b protein amounts were markedly lower compared with those in the distal intestine as described previously (34) . The Npt2b protein levels in the proximal intestine were not significantly different between Npt2b ϩ/ϩ mice and Npt2b ϩ/Ϫ mice at 4 wk of age. The amounts of Npt2b protein in the distal intestine were decreased in Npt2b ϩ/Ϫ mice compared with those in Npt2b ϩ/ϩ mice at 4 wk of age. (Fig. 2D) . Similar results were observed in mice at 20 wk of age (percentage of Npt2b protein expression in distal intestine of Npt2b ϩ/ϩ vs. Npt2b ϩ/Ϫ ; 100 Ϯ 4.55: 58.96 Ϯ 1.64%). The levels of PiT-1 mRNA in the proximal intestine were significantly increased in Npt2b ϩ/Ϫ mice at 20 wk of age, but not in Npt2b ϩ/Ϫ mice at 4 wk of age (Supplemental Fig. 1 -I and II; all supplemental material for this article is accessible on the journal website). However, the PiT-1 protein expression levels were not significantly changed in both the proximal and distal intestine of Npt2b ϩ/Ϫ mice compared with those of Npt2b ϩ/ϩ mice (Supplemental Fig. 1-III) .
Plasma P i , Ca, vitamin D, FGF23, and urinary P i and Ca excretion in Npt2b
ϩ/Ϫ mice. Plasma P i , Ca, 1,25(OH) 2 D 3 , and FGF23 levels in Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice fed the standard mice chow are shown in Fig. 3 . At 4 wk of age, plasma P i and Ca levels were significantly decreased in the Npt2b ϩ/Ϫ mice compared with the Npt2b ϩ/ϩ mice (Fig. 3A, a and b) . Plasma 1,25(OH) 2 D 3 levels were significantly increased in the Npt2b ϩ/Ϫ mice compared with the Npt2b ϩ/ϩ mice (Fig. 3, Ac) . Furthermore, plasma FGF23 levels were significantly decreased in the Npt2b ϩ/Ϫ mice compared with the Npt2b ϩ/ϩ mice (Fig. 3Ad) . The Npt2b ϩ/Ϫ mice also had significantly lower urinary P i excretion compared with Npt2b ϩ/ϩ mice (Fig. 3Ae ). In contrast, urinary Ca excretion levels were significantly increased in the Npt2b ϩ/Ϫ compared with Npt2b ϩ/ϩ mice (Fig. 3Af) .
At 20 wk of age, plasma P i , Ca, 1,25(OH) 2 D 3 , and FGF23 levels were not different between Npt2b ϩ/Ϫ and Npt2b ϩ/ϩ mice ( Fig. 3B, a-d) , Urinary P i excretion was significantly decreased in 20-wk-old Npt2b ϩ/Ϫ mice compared with agematched Npt2b ϩ/ϩ mice as described in the mice at 4 wk of age (Fig. 3Be) . Urinary Ca excretion was not different between Npt2b ϩ/Ϫ and Npt2b ϩ/ϩ mice (Fig. 3Bf) .
Intestinal Na ϩ -dependent P i transport activity in Npt2b
ϩ/Ϫ mice. At 4 and 20 wk of age, intestinal BBMV Na ϩ -dependent P i transport activity was assessed in Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice fed the standard mice chow (Fig. 4 ). Sodium-dependent P i uptake was linear for up to 60 s, with a slow increase persisting for 5 min (data not shown). Na ϩ -dependent P i transport activity in the proximal intestine tended to be reduced in the Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice at both 4 and 20 wk of age, but not significantly (Fig. 4 , Aa and Ba). In contrast, Na ϩ -dependent P i transport activity was significantly decreased in the distal intestine of Npt2b ϩ/Ϫ mice compared with that of the Npt2b ϩ/ϩ mice at both 4 and 20 wk of age (Fig.  4 , Ab and Bb). These data suggest that Na ϩ -dependent P i transport activity in the distal intestine affects plasma P i levels and urinary P i excretion.
Expression of renal Npt2a and Npt2c in Npt2b
ϩ/Ϫ mice. At 4 and 20 wk of age, renal Npt2a and Npt2c mRNA and protein levels were determined in Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice fed a normal P i diet (Fig. 5 ). Npt2a and Npt2c mRNA levels were not different between Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice (Fig. 5 , Aa, Ab, Ba, and Bb). Npt2a and Npt2c protein levels were significantly increased in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice at 4 wk of age, but not in the mice at 20 wk of age (Fig. 5 , Ac, Ad, Bc, and Bd). The levels of renal PiT-1/2 mRNA were not significantly changed in Npt2b ϩ/Ϫ mice at 4 and 20 wk of age (Supplemental Fig. 2-I and II) .
Expression of 25-hydroxyvitamin D-1␣-hydroxylase and 25-hydroxyvitamin D-24-hydroxylase mRNA in the kidney of Npt2b
ϩ/Ϫ mice. To further investigate P i homeostasis, we analyzed vitamin D metabolism in the kidney of Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice at 4 and 20 wk of age (Fig. 6 ). At 4 wk of age, the 25-hydroxyvitamin D-1␣-hydroxylase (1␣-OHase) mRNA levels were significantly increased in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice (Fig. 6Aa) . In contrast, 25-hydroxyvitamin D-24-hydroxylase (24OHase) mRNA levels were significantly decreased in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice at 4 wk of age (Fig. 6Ab) . At 20 wk of age, there were no differences in 1␣-OHase and 24OHase mRNA levels between Npt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice (Fig. 6B) . Adenine-induced renal failure model. To determine whether reduced Npt2b protein levels affect plasma P i levels in renal failure, we used an experimental mouse model with adenineinduced renal failure with hyperphosphatemia (Fig. 7) . On day 4, body weight was significantly decreased in adenineNpt2b ϩ/ϩ and Npt2b ϩ/Ϫ mice compared with control mice (Fig. 7B ). Plasma creatinine and P i levels were significantly elevated in the adenine-Npt2b ϩ/ϩ mice compared with nontreated Npt2b ϩ/ϩ mice (Fig. 7, C and D) . In contrast, plasma creatinine and P i levels were significantly lower in the adenineNpt2b ϩ/Ϫ than those in adenine-Npt2b ϩ/ϩ mice (Fig. 7, C and  D) . Plasma Ca levels were significantly increased in adenineNpt2b ϩ/ϩ and adenine-Npt2b ϩ/Ϫ mice compared with non- treated mice, respectively (Fig. 7E) . The levels of Npt2b protein in the distal intestine were not significantly different between adenine-treated and nontreated mice (Fig. 7F) . The levels of Npt2b protein were significantly lower in adeninetreated Npt2b ϩ/Ϫ than in adenine-treated Npt2b ϩ/ϩ mice (Fig.  7F ). The levels of NaP i transport activity were significantly reduced in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice, as described in Fig. 4 . There were no differences, however, 
DISCUSSION
To study the role of Npt2b in vivo, we generated Npt2b gene KO mice. There were no Npt2b Ϫ/Ϫ offspring at birth derived from intercrossing Npt2b ϩ/Ϫ mice, indicating that Npt2b
mice are embryonically lethal. Recently, Shibasaki et al. (39) reported that Npt2b Ϫ/Ϫ embryos die by 10.5 dpc during early embryogenesis, which could be due to P i deficiency at the parietal endoderm prior to the establishment of the placenta, where embryonic and maternal circulation are in close contact. Embryonic lethality of Npt2b Ϫ/Ϫ mice strongly suggests that
Npt2b has an essential role in supplying P i to embryos by active transport during early embryogenesis. In contrast, the heterozygotes (Npt2b ϩ/Ϫ ) were viable. Therefore, we characterized the phenotypes of heterozygous mice with regard to P i homeostasis.
In the present study, we investigated the amounts of Npt2b protein in Npt2b ϩ/Ϫ mice. The Npt2b protein levels in the distal intestine were significantly decreased in Npt2b ϩ/Ϫ mice compared with Npt2b ϩ/ϩ mice. At 4 wk (28 days) of age, Npt2b ϩ/Ϫ mice showed hypophosphatemia and hypophosphaturia, suggesting impaired intestinal P i transport and activation of renal P i reabsorption. In contrast, at 20 wk, Npt2b ϩ/Ϫ mice did not showed hypophosphatemia. At 4 wk, the body demand for P i is markedly increased and P i from the diet is absorbed through the intestine to support skeletal growth (41) . In the present study, the role of Npt2b in the weaning animals appeared to be more important than that in adult mice (20 wk) . Indeed, the levels of intestinal Npt2b protein are significantly increased in the suckling and weaning periods than in the adult stages (4) (Segawa H, Hanabusa E, Kaneko I, Miyamoto K, unpublished observations). Xu et al. (41) demonstrated that in rat small intestine, NaPi-IIb (Npt2b) gene expression decreased with age, and this observation correlates well with functional studies. Thus NaPi-IIb expression contributes to the ontogenic changes in intestinal P i absorption. In addition, Sabbagh et al. (35) reported the temporal effects on P i homeostasis after gene ablation (conditional Npt2b-KO) analyzed over 10 wk after tamoxifen treatment. In the adult animals, differences in serum P i levels were not detected between wild-type and conditional Npt2b-KO mice. Although Sabbagh et al. did not discuss the phenotypes of weaning conditional Npt2b-KO mice, adult conditional Npt2b-KO mice did not show hypophosphatemia (35) . These findings indicate that despite an apparent reduction in intestinal P i absorption, serum P i is maintained in the conditional Npt2b-KO animals via reduced urinary excretion (35) . In contrast, in weaning animals, the achievement of a positive external balance is dependent on intestinal absorption and the ability of the kidneys to reclaim filtered P i . Little P i is lost in the feces, reflecting its extensive absorption, a process stimulated by dietary P i deprivation and 1,25(OH) 2 (9, 34, 38, 41) .
Hyperphosphatemia is an important consequence of chronic kidney disease (CKD) (13, 14, 25) . Decreasing plasma P i concentrations is believed to be critical in the management of patients with CKD, especially those on dialysis (13, 14, 25) . Recently, Marks et al. (23) used an in situ intestinal loop technique to determine intestinal phosphate absorption in the 5 ⁄6 nephrectomy rat model of chronic renal failure (CRF) under disease conditions and reported that P i absorption in the duodenum and jejunum is not significantly altered, regardless of dietary P i intake level. These data indicate that in CRF, unlike in the kidney, P i transport across the small intestine is not reduced (23) . This makes intestinal P i absorption a potential target for the prevention and treatment of hyperphosphatemia (23) . Npt2b might thus be a primary target for the development of inhibitors of hyperphosphatemia. In the present study, we examined the role of Npt2b in preventing hyperphosphatemia in mice with adenine-induced renal failure. Mice with adenineinduced renal failure showed hyperphosphatemia and high levels of plasma creatinine. Npt2b ϩ/Ϫ mice had lower plasma P i and creatinine levels, suggesting that reduced intestinal Npt2b prevents hyperphosphatemia and the progression of renal failure in this mouse model. Indeed, reductions in P i intake have been linked to regression of proteinuria, stabilization of glomerular filtration rate, and, in some reports, improved survival in animal models of severe renal failure (1, 2, 7, 12, 15, 18, 19, 22) .
Finally, in the present study, we demonstrated that weanling Npt2b ϩ/Ϫ mice show hypophosphatemia and hypophosphaturia. Intestinal Npt2b protein levels were significantly decreased in Npt2b ϩ/Ϫ mice compared with those in Npt2b ϩ/ϩ mice. In Npt2b ϩ/Ϫ mice with adenine-induced renal failure, plasma P i levels were significantly decreased compared with those in Npt2b ϩ/ϩ mice. These data also suggest that Npt2b is an important therapeutic target for the prevention of hyperphosphatemia.
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